Table 1 Clinico-pathologic characteristics of rectal cancer patients
Characteristics | Patients (N = 74) |
|---|---|
Median age-years (range) | 72 (46–89) |
> 60 years | 60 (81%) |
< 60 years | 14 (19%) |
Sex | |
Male | 45 (61%) |
Female | 29 (39%) |
ECOG | |
0 | 41 (55%) |
1 | 31 (42%) |
2 | 2 (3%) |
Status | |
Death | 7 (10%) |
Alive without disease | 59 (78%) |
Alive with disease | 7 (10%) |
N/A | 1 (1%) |
T Downstaging | |
0 | 28 (38%) |
1 | 39 (53%) |
N/A | 7 (9%) |
N Downstaging | |
0 | 20 (27%) |
1 | 47 (64%) |
N/A | 7 (9%) |
Grade | |
Low | 19 (26%) |
High | 47 (63%) |
N/A | 8 (11%) |
Stage | |
II | 4 (6%) |
III | 69 (93%) |
N/A | 1 (1%) |
Neoadjuvant Treatment | |
RT + Fluoropyrimidines based | 73 (99%) |
Other | 1 (1%) |
Treatment toxicity | |
Yes | 30 (41%) |
No | 44 (59%) |
Pathological Response | |
Complete | 9 (12%) |
Partial | 27 (37%) |
Minimun | 38 (51%) |
DEK | |
Low | 26 (35%) |
High | 48 (65%) |